Pfizer Inc. (TSX:PFE)
Canada · Delayed Price · Currency is CAD 12.23
+0.04 (0.33%)
Oct 6, 2026, 3:59 PM EST
Pfizer Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 222,887 | 194,115 | 216,323 | 214,682 | 389,279 | 419,434 | |
Market Cap Growth | 2.68% | -10.27% | 0.76% | -44.85% | -7.19% | 60.88% |
Enterprise Value | 296,943 | 258,896 | 300,155 | 241,386 | 390,803 | 432,661 |
Last Close Price | 12.23 | 10.72 | 10.93 | 11.34 | 20.41 | 23.85 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 36.25 | 18.22 | 18.72 | 76.72 | 9.17 | 15.08 |
PS Ratio | 2.47 | 2.26 | 2.36 | 2.73 | 2.84 | 4.08 |
PB Ratio | 1.84 | 1.63 | 1.70 | 1.82 | 3.00 | 4.28 |
P/TBV Ratio | - | - | - | - | 314.00 | 116.42 |
P/FCF Ratio | 14.30 | 15.60 | 15.29 | 33.92 | 11.05 | 11.10 |
P/OCF Ratio | 11.72 | 12.10 | 11.80 | 18.68 | 9.83 | 10.17 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.28 | 3.02 | 3.28 | 3.07 | 2.85 | 4.21 |
EV/EBITDA Ratio | 7.94 | 7.34 | 9.25 | 14.54 | 6.44 | 10.66 |
EV/EBIT Ratio | 11.08 | 9.85 | 13.41 | 28.94 | 7.25 | 12.67 |
EV/FCF Ratio | 19.05 | 20.81 | 21.21 | 38.14 | 11.09 | 11.45 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.74 | 0.78 | 0.76 | 0.84 | 0.41 | 0.53 |
Debt / EBITDA Ratio | 2.41 | 2.54 | 2.84 | 5.44 | 0.85 | 1.26 |
Debt / FCF Ratio | 5.78 | 7.45 | 6.86 | 15.72 | 1.51 | 1.39 |
Net Debt / Equity Ratio | 0.61 | 0.62 | 0.53 | 0.70 | 0.17 | 0.13 |
Net Debt / EBITDA Ratio | 2.04 | 2.10 | 2.08 | 4.98 | 0.37 | 0.32 |
Net Debt / FCF Ratio | 4.71 | 5.96 | 4.77 | 13.07 | 0.64 | 0.35 |
Asset Turnover | 0.31 | 0.30 | 0.29 | 0.28 | 0.53 | 0.48 |
Inventory Turnover | 1.49 | 1.41 | 1.63 | 2.50 | 3.78 | 3.59 |
Quick Ratio | 0.85 | 0.80 | 0.82 | 0.59 | 0.88 | 1.10 |
Current Ratio | 1.27 | 1.16 | 1.17 | 0.91 | 1.22 | 1.40 |
Return on Equity (ROE) | 5.01% | 8.89% | 9.06% | 2.35% | 36.22% | 31.87% |
Return on Assets (ROA) | 5.78% | 5.68% | 4.42% | 1.86% | 13.15% | 10.05% |
Return on Invested Capital (ROIC) | 13.49% | 13.87% | 10.83% | 4.78% | 35.96% | 27.65% |
Return on Capital Employed (ROCE) | 11.20% | 11.20% | 9.10% | 3.50% | 25.70% | 19.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.76% | 5.49% | 5.34% | 1.30% | 10.91% | 6.63% |
FCF Yield | 6.99% | 6.41% | 6.54% | 2.95% | 9.05% | 9.01% |
Dividend Yield | 6.30% | 22.00% | 22.12% | 19.10% | 10.61% | 8.28% |
Payout Ratio | 225.77% | 125.74% | 118.44% | 436.39% | 28.63% | 39.72% |
Buyback Yield / Dilution | -0.34% | -0.23% | 0.16% | 0.42% | -0.44% | -1.35% |
Total Shareholder Return | 5.96% | 21.78% | 22.28% | 19.52% | 10.17% | 6.93% |